Date | Day | Title | Lecturer | hours | Room | |
UNIT 1: Introduction to Nanotechnology (15 ECTS) | ||||||
Lesson 1.1. Basic principles I | ||||||
w1 | 10/15/2018 | Mon | 1.1.1 The wider context of Nanotechnology and Nanomedicine | E. Efstathopoulos | 5 | Attiko |
17/10/18 | Wed | 1.1.2 The Fundamental Science of Nanotechnology | D. Tsoukalas | 5 | Pharma | |
19/10/18 | Fri | 1.1.2 The Fundamental Science of Nanotechnology | D. Tsoukalas | 5 | Pharma | |
Lesson 1.2. Basic principles II | ||||||
w2 | 22/10/18 | Mon | 1.2.1 Main types of nanosystems | C. Demetzos - A. Pippa | 5 | Pharma |
24/10/18 | Wed | 1.2.1 Main types of nanosystems | H. Iatrou | 5 | Pharma | |
26/10/18 | Fri | 1.2.1 Main types of nanosystems | H. Iatrou | 5 | Pharma | |
w3 | 29/10/18 | Mon | 1.2.1 Main types of nanosystems | E. Spyratou, M. Gazouli, A,. Lyberopoulou | 5 | Pharma |
31/10/18 | Wed | 1.2.2 Nanostructured materials | M. Gazouli, A,. Lyberopoulou | 5 | Pharma | |
02/11/18 | Fri | 1.2.3 Physiochemical characterization techniques of nanosystems | E. Spyratou | 5 | Pharma | |
w4 | 05/11/18 | Mon | 1.2.3 Physiochemical characterization techniques of nanosystems | E. Spyratou | 5 | Pharma |
07/11/18 | Wed | 1.2.3 Physiochemical characterization techniques of nanosystems | H. Iatrou, A. Pippa | 5 | Pharma | |
09/11/18 | Fri | 1.2.4 Principles of Nanomedicine | E. Efstathopoulos, A. Lyberopoulou | 5 | Attiko | |
Lesson 1.3. Basic principles III | ||||||
w5 | 12/11/18 | Mon | 1.3.1 Short overview of in-vivo imaging techniques | E. Efstathopoulos | 5 | Attiko |
14/11/18 | Wed | 1.3.1 Short overview of in-vivo imaging techniques | P. Karaiskos, E. Pantelis, A. Chatziioannou, E. Efstathopoulos | 5 | Attiko | |
16/11/18 | Fri | 1.3.1 Short overview of in-vivo imaging techniques | N. Kelekis, E. Brountzos, S. Chatziioannou | 5 | Attiko | |
w6 | 19/11/18 | Mon | 1.3.1 Short overview of in-vivo imaging techniques | N. Kelekis, E. Brountzos, S. Chatziioannou | 5 | Attiko |
21/11/18 | Wed | 1.3.1 Short overview of in-vivo imaging techniques | G. Tsivgoulis, S. Sgouros, S. Chatziioannou | 5 | Attiko | |
23/11/18 | Fri | 1.3.2. Future perspectives and challenges - Students’ project | E. Efstathopoulos | 5 | Attiko | |
w7 | 30/11/18 | Fri | Exams of Unit 1 | E. Efstathopoulos | Attiko | |
UNIT 2 : Applications of Nanotechnology in Medicine (15 ECTS) | ||||||
Lesson 2.1. Basics of Nanomedicine | ||||||
w8 | 03/12/18 | Mon | 2.1.1 Enabling technologies for oral drug delivery | 3 h Reppas | 5 | Pharma |
2.1.2 Introduction to pharmakocinetics (Absorption Distribution, Metabolism, Excretion) | 2 h Karalis | |||||
05/12/18 | Wed | 2.1.3 Introduction to Quality by Design I and II | 3 h Rekkas | 5 | Pharma | |
2.1.4 Choosing the optimal enabling formulation for oral drug delivery | 2 h Reppas | |||||
07/12/18 | Fri | 2.1.5 Biorelevant in vitro performance of orally administrated dosage forms | 2 h Vertzoni | 5 | Pharma | |
2.1.6 Modelling and simulation in drug development and approval | 3 h Dokometzidis | |||||
w9 | 10/12/18 | Mon | 2.1.7 Solubility and solution properties of drugs | 3 h Vertzoni | 5 | Pharma |
2.1.8 Drug stability and principles of Pharmaceutical Technology | 2 h Pippa | |||||
12/12/18 | Wed | 2.1.9 Introduction to the lipidic structures and to the crystalline state of matter | 3 h Demetzos | 5 | Pharma | |
2.1.10 Introductions to Polymers in Pharmaceutics | 2 h Iatrou | |||||
14/12/18 | Fri | 2.1.11 Introduction to modified release systems for drug delivery | 3 h Vlachou | 5 | Pharma | |
2.1.12 Introduction to skin pathology and nanoparticulate’s penetration mechanism | 2 h Rallis | |||||
w10 | 17/12/18 | Mon | 2.1.13 Nanomolecular diagnostics and in vitro diagnostics | Papaparaskevas | 5 | Pharma |
19/12/18 | Wed | 2.1.14 Biosensors, nanocrystals, quantum dots, magnetic nanoparticles II (applications) | Mouzakis | 5 | Pharma | |
21/12/18 | Fri | 2.1.15 Imaging in interventional radiology | 1 h Filippiadis-Spiliopoulos | 5 | Attiko | |
2.1.16 αναζήτηση βιβλιογραφίας (2 εσωτερικοί – 4 h)10 | Mastorakos OK 2 ώρες | |||||
Lesson 2.2 Basic applications of nanotechnology in therapy | ||||||
w11 | 08/01/19 | Tue | 2.2.1 Lipidic nanocarriers. Liposomes, chimeric lipidic nanoparticles and stimuli responsive | C. Demetzos - A. Pippa | 5 | Pharma |
09/01/19 | Wed | 2.2.2 Nanogels and polymeric micelles | 3 h Iatrou | 5 | Pharma | |
2.2.4 Clinical therapeutics and nanotechnology | 2 h Markantoni-Kyroudis | |||||
11/01/19 | Fri | 2.2.4 Nanoparticulate formulations and skin diseases | 5 h Rallis | 5 | Pharma | |
w12 | 14/01/19 | Mon | 2.2.5 Introduction and applications to Theranostics | 3h - MOUZAKIS – LYBEROPOULOU | 5 | Attiko |
2.2.6 Applications of nanotechnology in nuclear therapy and in Radiotherapy | 2 hKouloulias -Platoni) | |||||
16/01/19 | Wed | 2.2.7 Applications of nanotechnology in biophotonic therapy | 3 h Kouloulias | 5 | Attiko | |
2.2.8 Applications of nanotechnology in vaccines | 2 h Pippa | |||||
18/01/19 | Fri | 2.2.9 Applications of nanotechnology in surgery | 2hTheothoropoulos, Nikiteas | 5 | Pharma | |
2.2.10 Αpplications of Nanotechnology in interventional radiology | 1 h Fillippiadis - Spiliopoulos | |||||
2.2.11 Nanobubbles | 2h Vavouranakis | |||||
Lesson 2.3 Theranostics and regenerative medicine | ||||||
w13 | 21/01/19 | Mon | 2.3.1. Applications of nanotechnology in Orthopaedics | 3h Olga Savvidou | 5 | Attiko |
2.3.2. Physical properties of stimuli responsive biomaterials | 2 hMouzakis | |||||
23/01/19 | Wed | 2.3.3. Smart biomaterials | 5h Iatrou, Mouzakis, Pippa | 5 | Pharma | |
25/01/19 | Fri | 2.3.4. Types of embryonic, fetal and adult stem cells | 5 h Roubelaki | 5 | Pharma | |
w14 | 28/01/19 | Mon | 2.3.5. Application of smart biomaterials in regenerative medicine | 5hN. Papaioannou - Triantafyllopoylos | 5 | Attiko |
31/01/19 | Thu | 2.3.6. Future perspectives and challenges (students’sproject 5h) | 5 | Pharma | ||
01/02/19 | Fri | 2.3.7. Implementation of M.Sc. Thesis | G. Mastorakos, Th. Papaioannou, Pharma | 5 | Pharma | |
w15 | 08/02/19 | Fri | Exams of Unit 2 | Pharma | ||
UNIT 3: Nano-toxicity and Regulatory aspects (10 ECTS) | ||||||
Lesson 3.1. Toxicity aspects | ||||||
w16 | 11/02/19 | Mon | 3.1.1. Potential cause of nanotoxicity | M. Rallis | 5 | Pharma |
13/02/19 | Wed | 3.1.2. Interaction of nanoparticles | M. Gazouli, A. Lyberopoulou | 5 | Pharma | |
w17 | 18/02/19 | Mon | 3.1.3. Toxicity studies | M. Gazouli | 5 | Pharma |
20/02/19 | Wed | 3.2.1. Nanodrugs in clinical practice | C. Demetzos, A. Pippa | 5 | Pharma | |
w18 | 25/02/19 | Mon | 3.2.1. Nanodrugs in clinical practice | C. Demetzos, A. Pippa | 5 | Pharma |
27/02/19 | Wed | 3.2.2. Advanced nanoparticle systems | P. Bouzioti, S. Pispas | 5 | Pharma | |
w19 | 04/03/19 | Mon | 3.3.1. Nanomaterials and Manufacturing: framing the ethical issues | D. Mouzakis | 5 | Pharma |
06/03/19 | Wed | 3.3.2. Toxicology and human health, 3.3.3. Nanosimilars | D. Mouzakis, C. Demetzos | 5 | Pharma | |
w20 | 13/03/19 | Wed | 3.3.4. Regulatory issues of nanomedicines (FDA, EMA) | C. Gardikis | 5 | Pharma |
15/03/19 | Fri | 3.3.5. Future perspectives and challenges - Students’ project | M. Gazouli | 5 | Pharma | |
w21 | 18/03/19 | Mon | Presentation of Dissertation Protocols (students` presentations) | E. Efstathopoulos, C. Demetzos, M. Gazouli | 5 | Attiko |
20/03/19 | Wed | Presentation of Dissertation Protocols (students` presentations) | E. Efstathopoulos, C. Demetzos, M. Gazouli | 5 | Attiko | |
3/22/2019 | Fri | Regulatory issues of nanomedicines and nanocosmetics & applications of nanotechnology in cosmeotology | C. Gardikis | 5 | ||
w22 | 29/03/19 | Fri | Exams of Unit 3 | Pharma | ||
APR - JUL/19 | DISSERTATION (20 ECTS) | |||||
2-3/9/19 | Exams | Attiko - Pharma | ||||
4-6/9/19 | Dissertations' presentations | Attiko - Pharma |